- Home
- GHG vs SABS Comparison
GHG vs SABS Comparison
Compare GHG & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GHG
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
Current Price
Current Price
Company Overview
Basic Information| Metric | GHG | SABS |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.6M | 201.4M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | GHG | SABS |
|---|---|---|
| Price | $1.34 | $3.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.80 |
| AVG Volume (30 Days) | 22.0K | ★ 262.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.81% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.02 | N/A |
| Revenue Next Year | $8.26 | N/A |
| P/E Ratio | $5.76 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.32 | $1.00 |
| 52 Week High | $2.83 | $6.60 |
Technical Indicators
Market Signals| Indicator | GHG | SABS |
|---|---|---|
| Relative Strength Index (RSI) | 32.79 | 43.42 |
| Support Level | N/A | $3.75 |
| Resistance Level | $2.29 | $4.16 |
| Average True Range (ATR) | 0.04 | 0.27 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 15.38 | 38.69 |
Price Performance
Historical ComparisonAbout GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.